Vycor Medical, Inc.
VYCO
$0.0648
-$0.0041-5.95%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -59.80K | -10.00K | -30.60K | -93.10K | -51.90K |
| Total Depreciation and Amortization | 15.70K | 15.70K | 15.60K | 15.10K | 15.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.70K | 0.00 | 7.30K | 2.20K | 2.80K |
| Change in Net Operating Assets | 49.90K | 80.30K | 9.50K | 81.20K | 19.00K |
| Cash from Operations | 10.50K | 86.00K | 1.90K | 5.50K | -14.90K |
| Capital Expenditure | -4.40K | -- | -- | -5.90K | -3.50K |
| Sale of Property, Plant, and Equipment | -700.00 | 0.00 | 700.00 | -- | -500.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.00K | 0.00 | 700.00 | -5.90K | -4.00K |
| Total Debt Issued | 61.00K | -- | -- | 51.50K | 63.10K |
| Total Debt Repaid | -28.10K | -10.60K | -16.00K | -62.90K | -28.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.90K | -10.60K | -16.00K | -11.40K | 34.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.30K | 75.40K | -13.40K | -11.80K | 15.70K |
